EF
TXG icon

Empowered Funds’s 10x Genomics TXG Stock Holding History

Empowered Funds’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
+7,894
New +$207K ﹤0.01% 1861
2021
Q3 		– Sell
-10,580
Closed -$2.07M – 284
2021
Q2 		$2.07M Sell
10,580
-1,036
-9% -$187K 0.26% 97
2021
Q1 		$1.65M Hold
11,616
– – 0.32% 121
2020
Q4 		$1.65M Buy
+11,616
New +$1.69M 0.32% 121

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Empowered Funds's TXG Position: Q2 2026 in Review

Empowered Funds opened a new position in 10x Genomics (TXG) in Q2 2026: 7,894 shares worth $303K. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings. This is a return to the name: Empowered Funds previously reported a position in TXG as recently as Q2 2021.

Empowered Funds first reported a position in TXG in Q4 2020 and has held it in 4 quarters since. The position peaked at $2.07M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Empowered Funds held 7,894 shares of 10x Genomics worth $303K as of Q2 2026.
  • 10x Genomics was a new Empowered Funds position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1861 holding.
  • Empowered Funds first reported a position in 10x Genomics in Q4 2020 and has held it in 4 quarters since.
  • Empowered Funds's 10x Genomics position peaked at $2.07M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.